Mangoceuticals Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 67 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Mangoceuticals Inc is 5.68, ranking 67 out of 75 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 84.25K, representing a year-over-year decrease of 36.83%, while its net profit experienced a year-over-year decrease of 295.76%.
Key Metrics
The current valuation score of Mangoceuticals Inc is 7.50, ranking 28 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 0.01, which is 242.67% below the recent high of 0.03 and 6933109.33% above the recent low of -519.98.
No earnings forecast score is currently available for Mangoceuticals Inc. The Healthcare Providers & Services industry's average is 7.58.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Mangoceuticals Inc is 3.30, ranking 72 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 0.78 and the support level at 0.16, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Mangoceuticals Inc is 1.20, ranking 70 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
